<DOC>
	<DOCNO>NCT01106703</DOCNO>
	<brief_summary>The aim study evaluate efficacy PG102 lowering level total IgE asymptomatic subject atopy .</brief_summary>
	<brief_title>The Effects PG102 , Water Soluble Extract From Actinidia Arguta , Serum Total IgE Levels</brief_title>
	<detailed_description />
	<criteria>subject atopy allergyrelated symptom subject total IgE level 300IU/ml acquisition write informed consent prior commencement study serious clinical symptom normal laboratory test result ; case abnormal finding , subject whose condition deem severe judgement investigator individual normal level total serum IgE ue one allergic drug serious clinical condition ( malignancy , severe cardiovascular disease etc . ) serious mental disorder pregnant woman woman childbearing potential within 3 month subject participate clinical trial past 6months individual plan participate another clinical trial trial subject history kiwi allergy subject whose condition inappropriate investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>atopy , IgE</keyword>
</DOC>